Biotech M&A
The latest news about Biotech M&A: headlines, AI summaries and the full story from every source.
- Teva Submits $125M Bid for BioXcel Assets in Bankruptcy Auction
- Barclays Analyst Predicts Biotech M&A Market Reopening After Prolonged Downturn
- Eli Lilly Acquires AtaiBeckley in $2.8 Billion Deal; Cathie Wood Favors Competitor Compass Pathways
- Novartis Faces Patent Cliff and Bets on Pipeline to Offset Revenue Losses
- Connecticut Innovations Reports Record $66.5 Million in Proceeds for FY2026
- Incyte Near $2 Billion Deal for Star Therapeutics